
The Federal Trade Commission (FTC) on Thursday, July 1, voted to expand the regulatory agency’s enforcement powers, a signal of Democratic commissioners’ willingness to crack down on alleged anti-competitive behavior, reported The Verge.
The Democratic-controlled Commission voted 3-2 along party lines to repeal a 2015 policy statement that blocked the regulatory agency from challenging “unfair methods of competition” that don’t violate existing antitrust laws. The update comes at a time when federal and state regulators are sinking their teeth into investigations of the market power of tech giants.
“In practice, the 2015 statement has doubled down on the agency’s long standing failure to investigate and pursue unfair methods of competition,” Chair Lina Khan said at the meeting, the first under her charge.
The guidance had “only hindered the agency’s enforcement efforts,” she said.
Fellow Democrats on the Commission, Rohit Chopra and Rebecca Slaughter, voted with Khan in repealing the Obama-era policy statement, while Republican commissioners Christine Wilson and Noah Phillips opposed the measure.
Wilson argued that without the guidance in place, antitrust enforcement will “reflect political motivations.”
“Enforcement based on political motivations rather than economic analysis would produce outcomes that are unpredictable and lack credibility,” Wilson said.
Tech industry groups had also urged the FTC against repealing the 2015 policy statement.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Trump Administration Steps Up Pressure On EU Digital Laws
May 18, 2025 by
CPI
Elton John Slams UK Government’s AI Copyright Plan as ‘Theft’
May 18, 2025 by
CPI
Anthropic’s Legal Team Blames AI “Hallucination” for Citation Error in Copyright Lawsuit
May 18, 2025 by
CPI
Intel Challenges €376 Million EU Antitrust Fine in Ongoing Legal Battle
May 18, 2025 by
CPI
FTC Chairman Highlights Fiscal Responsibility and Consumer Protection in House Testimony
May 18, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas